Immunotherapeutics and targeted therapies are emerging as promising treatment options for various cancer types.

Rapid expansions in the applications of MRI and an increased medical awareness of MRI systems as a diagnostic tool have triggered strong growth in this market in recent years.

The industry will also have more biologics and synthetic anti-inflammatory agents for both asthma and COPD, as companies look to identify and offer treatments for multiple patient sub-groups.

Defibrillators are essential in improving the quality of life and overall well-being.

The biopharmaceutical contract manufacturing market has significantly expanded over the past years